These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25712934)

  • 21. [The prevention and treatment of vascular calcification.].
    Kawakami K; Ohya M; Shigematsu T
    Clin Calcium; 2019; 29(2):231-236. PubMed ID: 30679405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
    Mori H; Okada Y; Tanaka Y; Hashimoto O
    Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts.
    Viegas C; Araújo N; Marreiros C; Simes D
    Aging (Albany NY); 2019 Jun; 11(12):4274-4299. PubMed ID: 31241466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease.
    Kusumi K; Kremsdorf R; Kakajiwala A; Mahan JD
    Adv Chronic Kidney Dis; 2022 May; 29(3):275-282. PubMed ID: 36084974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate binders in moderate chronic kidney disease: where do we stand?
    Bellasi A; Cozzolino M; Adragao T; Di Iorio B; Russo D
    J Nephrol; 2013; 26(6):993-1000. PubMed ID: 23543481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects.
    Bover J; Aguilar A; Arana C; Molina P; Lloret MJ; Ochoa J; Berná G; Gutiérrez-Maza YG; Rodrigues N; D'Marco L; Górriz JL
    Front Med (Lausanne); 2021; 8():642718. PubMed ID: 34095165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone health and vascular calcification relationships in chronic kidney disease.
    Spasovski GB
    Int Urol Nephrol; 2007; 39(4):1209-16. PubMed ID: 17899431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research on kidney and mineral metabolism in Japan: past, present, and future.
    Mizobuchi M; Ogata H; Koiwa F; Kinugasa E; Akizawa T
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):4-8. PubMed ID: 28005175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone alkaline phosphatase in CKD-mineral bone disorder.
    Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
    Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease-mineral-bone disorder: a new paradigm.
    Moe SM; Drüeke T; Lameire N; Eknoyan G
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):3-12. PubMed ID: 17200038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease.
    Torres PA; De Broe M
    Kidney Int; 2012 Jul; 82(1):19-25. PubMed ID: 22437409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.
    Grabner A; Mazzaferro S; Cianciolo G; Krick S; Capelli I; Rotondi S; Ronco C; La Manna G; Faul C
    Contrib Nephrol; 2017; 190():83-95. PubMed ID: 28535521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and significance of abdominal aortic calcification in chronic kidney disease.
    Hanada S; Ando R; Naito S; Kobayashi N; Wakabayashi M; Hata T; Sasaki S
    Nephrol Dial Transplant; 2010 Jun; 25(6):1888-95. PubMed ID: 20061316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.
    Nikolov IG; Joki N; Nguyen-Khoa T; Ivanovski O; Phan O; Lacour B; Drüeke TB; Massy ZA; Dos Reis LM; Jorgetti V; Lafage-Proust MH
    Bone; 2010 Jul; 47(1):156-63. PubMed ID: 20406703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mineral and bone disturbances associated with chronic kidney disease].
    Suchowierska E; Myśliwiec M
    Pol Merkur Lekarski; 2010 Feb; 28(164):138-43. PubMed ID: 20369744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.